Clinical utility of amyloid PET imaging with (18)F-florbetapir: a retrospective study of 100 patients.

API has a clear impact on the investigation of young-onset or complex dementia while reducing the overall burden of investigations. It was most useful in younger patients, atypical presentations or individuals with multiple possible causes of cognitive impairment.